Company Overview
About AbbVie
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Business Model & Competitive Advantage
The company has successfully navigated the Humira patent cliff that began in 2023, when biosimilar competitors entered the US market after years of exclusivity. AbbVie's strategy to offset Humira erosion centered on Skyrizi (risankizumab, for psoriasis and Crohn's disease) and Rinvoq (upadacitinib, for rheumatoid arthritis and other immune conditions), both of which have grown rapidly to partially offset Humira's revenue decline. Revenue in 2024 was approximately $55 billion.
Competitive Landscape 2025–2026
In 2025, AbbVie completed its $8.7 billion acquisition of Cerevel Therapeutics to bolster its neuroscience pipeline with treatments for schizophrenia and Parkinson's disease. The company also acquired Aliada Therapeutics (Alzheimer's focused) for $1.4 billion. AbbVie's aesthetics franchise (Botox via Allergan acquisition, Juvederm) remains a significant revenue contributor. The company's 2025-2026 strategic priorities include advancing its neuroscience and oncology pipeline, executing the Allergan integration fully, and managing pricing pressures from the Inflation Reduction Act's drug negotiation provisions.
Open Positions
Reddit Discussions
Key Differentiators
Market Leader
AbbVie is recognized as a market leader in the Healthcare sector, demonstrating strong industry presence and customer trust.
Enterprise Scale
With $55000M in revenue, AbbVie operates at enterprise scale with proven market validation.
Frequently Asked Questions
Not So Random Others
Quantinuum
Quantinuum is a Cambridge, UK and Broomfield, Colorado-based integrated quantum computing company — majority owned by Honeywell (NASDAQ: HON) with $625+ million in total funding including a $300 milli
Hermes Robotics
Hermes Robotics is an autonomous mobile robot (AMR) and warehouse automation company developing robots and software for logistics and fulfillment operations in warehouses, distribution centers, and ma
Duckie
Duckie is a San Francisco-based AI customer support platform — backed by Y Combinator (W24) with $500,000 in funding from Y Combinator, Andreessen Horowitz, Greylock, KungHo Fund, Netflix, and 5 addit
Zeffy
Zeffy is a Montreal-based fundraising platform for nonprofit organizations that charges zero platform fees on donations — asking donors to optionally contribute a tip to cover Zeffy's operating costs
Oda Studio
Oda Studio is a United States-based AI-powered interior design platform — backed by Y Combinator (W20) — providing homebuyers, renters, and design enthusiasts with AI tools to discover their personal
Bucket Robotics
Bucket Robotics is an autonomous mobile robot (AMR) company that designs modular, rapidly deployable robots for warehouse automation and industrial material handling. Unlike traditional warehouse auto
Compare AbbVie with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from AbbVie? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim AbbVie Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention AbbVie vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →